Low diagnostic yield of presurgical genetic testing in adult patients with epilepsy
Epilepsia · 2026
DOI: 10.1002/epi.70291 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Clara Jünemann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Center Hessen, Philipps-University, Marburg, Germany. Hauptthemen laut MEDLINE: Epilepsy, Genetic Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHGRI NIH HHS, Clinical Research Fund, Cumming School of Medicine, University of Calgary..
Abstract (Originalsprache)
Objective
To determine the diagnostic yield of genetic testing in patients undergoing presurgical evaluation for epilepsy.
Methods
We conducted a cohort study including 115 adult patients who underwent presurgical evaluation in the Calgary Epilepsy Program between 2019 and 2023 and who had undergone research exome sequencing. A curated epilepsy gene panel comprising 765 Online Mendelian Inheritance in Man (OMIM)‐listed epilepsy‐associated genes was applied. Variants were classified according to American College of Medical Genetics and Genomics guidelines and assessed for clinical relevance and association with postsurgical outcomes.
Results
Pathogenic or likely pathogenic variants in DEPDC5 , NPRL2 , KCNT2 , and PRRT2 were identified, respectively, in 4 individuals (3.5%, 4/115). All variants met stringent quality criteria with high pathogenicity scores (Combined Annotation Dependent Depletion (CADD) 34–37) and absent or extremely low population frequencies in gnomAD v4.1. None of these patients had intellectual disability, and only one patient ( PRRT2 ) had a positive family history. The patient with the KCNT2 variant underwent epilepsy surgery with good outcome (Engel class ID). Significance This presurgical cohort demonstrates a low diagnostic yield of genetic testing in adult epilepsy surgery candidates. However, three of four patients with (likely) pathogenic variants did not have features that would have prompted clinical genetic testing, indicating that their genetic diagnosis would have been missed based on typical clinical genetic testing criteria in many jurisdictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epilepsy Center Hessen, Philipps-University, Marburg, Germany.
- Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
- Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
- Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
- Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Clara Jünemann, Amanda Stuart, Navprabhjot Kaur, Samuel Wiebe, Nathalie Jette, Felippe Borlot, Susanne Knake, Ping Yee Billie Au, Karl Martin Klein
Förderung
- NHGRI NIH HHS
- Clinical Research Fund, Cumming School of Medicine, University of Calgary.
Zitieren
APA
Jünemann, C., Stuart, A., Kaur, N., Wiebe, S., Jette, N., Singh, S., Borlot, F., Knake, S., Calgary Comprehensive Epilepsy Program Collaborators, Billie Au, P. Y., & Klein, K. M. (2026). Low diagnostic yield of presurgical genetic testing in adult patients with epilepsy. Epilepsia. https://doi.org/10.1002/epi.70291
Vancouver
Jünemann C, Stuart A, Kaur N, Wiebe S, Jette N, Singh S, et al. Low diagnostic yield of presurgical genetic testing in adult patients with epilepsy. Epilepsia. 2026. doi:10.1002/epi.70291
BibTeX
@article{Jnemann2026,
author = {Jünemann, Clara and Stuart, Amanda and Kaur, Navprabhjot and Wiebe, Samuel and Jette, Nathalie and Singh, Shaily and Borlot, Felippe and Knake, Susanne and Calgary Comprehensive Epilepsy Program Collaborators, Calgary Comprehensive Epilepsy Program Collaborators and Billie Au, Ping Yee and Klein, Karl Martin},
title = {Low diagnostic yield of presurgical genetic testing in adult patients with epilepsy},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70291}
}
EUVIMED